Fuji Research Park, Kyowa Hakko Kirin Co, Ltd, 1188 Shimotogari, Nagaizumi-cho, Suntou-gun, Shizuoka 411-8731, Japan.
Bioorg Med Chem Lett. 2010 Feb 1;20(3):1090-3. doi: 10.1016/j.bmcl.2009.12.028. Epub 2009 Dec 11.
A series of benzofuran derivatives were prepared to study their antagonistic activities to the A(2A) receptor. Replacement of the ester group of the lead compound 1 with phenyl ring improved the PK profile, while modifications of the amide moiety showed enhanced antagonistic activity. From these studies, compounds 13c, 13f, and 24a showed good potency in vitro and were identified as novel A(2A) receptor antagonists suitable for oral activity evaluation in animal models of catalepsy.
我们合成了一系列苯并呋喃衍生物,以研究它们对 A(2A)受体的拮抗活性。将先导化合物 1 的酯基替换为苯环,改善了其 PK 特征,而酰胺部分的修饰则增强了其拮抗活性。在这些研究中,化合物 13c、13f 和 24a 表现出良好的体外活性,被鉴定为新型 A(2A)受体拮抗剂,适合在僵住症动物模型中进行口服活性评价。